2Womer R B. The cellular biology of bone tumors[J]. Clin Orthop,1991(262):12-21.
3Butler M S, Robertson W W Jr,Rate W,et al. Skeletal sequelae of radiation therapy for malignant childhood tumors[J]. Clin Orthop,1990(251):235-240.
4Burgert EO Jr, Nesbit M E, Garnsey L A, et al. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II[J]. J Clin Oncol, 1990,8(9):1514-1524.
5Rosen G, Caparros B, Nirenberg A, et al. Ewing's sarcoma:ten-year experience with adjuvant chemotherapy [J]. Cancer,1981,47(9):2204-2213.
6Rosen G. The current management of malignant bone tumours:where do we go from here? [J]. Med J Aust, 1988,148(8):373-377.
7Marcus R B Jr, Graham-Pole J R, Springfield D S,et al. Highrisk Ewing's sarcoma: end-intensification using autologous bone marrow transplantation[J]. Int J Radiat Oncol Biol Phys, 1988,15(1):53-59.
8Jurgens H, Exner U, Kuhl J, et al. High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma[J]. Cancer Chemother Pharmacol, 1989,24 Suppl 1:40-44.
9Dirix L Y, Van-Oosterom A T. The role of ifosfamide in the treatment of adult soft tissue sarcomas, Ewing's sarcoma, and osteosarcoma: a review[J]. Semin Oncol, 1990,17(2 Suppl 4):50-57.
10Meyer W H, Kun L, Marina N,et al. Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone[J]. J Clin Oncol,1992,10(11):1737-1742.
